Theriva Biologics, Inc. (NYSE:TOVX) Q4 2023 Earnings Call Transcript
Theriva Biologics, Inc. beats earnings expectations. Reported EPS is $-0.34, expectations were $-0.41. Theriva Biologics, Inc.
March 26th, 2024 - News Transcripts
November 20th, 2023 - News Transcripts
Returns since its inception in May 2014 (through May 20, 2024)